Neuronal nitric oxide synthase-rescue of dystrophin/Utrophin double knockout mice does not require nNOS localization to the cell membrane

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Wehling Henricks, Michelle ^a   Tidball, James G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; CD68 ANTIGEN; DYSTROPHIN; NEURONAL NITRIC OXIDE SYNTHASE; UTROPHIN; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOSOL; DIAPHRAGM DISEASE; DOWN REGULATION; HEART MUSCLE FIBROSIS; HISTOLOGY; KNOCKOUT MOUSE; LIFESPAN; MACROPHAGE; MOUSE; MUSCLE ATROPHY; MYOFIBROSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RHABDOMYOLYSIS; SARCOLEMMA; SIGNAL TRANSDUCTION; SURVIVAL RATE; TRANSGENE; WILD TYPE; ANIMAL; BODY WEIGHT; FEMALE; FIBROSIS; GENE INACTIVATION; GENETICS; INFLAMMATION; MALE; METABOLISM; MOUSE MUTANT; MUSCULAR DYSTROPHY; PATHOLOGY; PATHOPHYSIOLOGY; PROTEIN TRANSPORT; SKELETAL MUSCLE; SURVIVAL; TRANSGENIC MOUSE;

MUS;

ANIMALS; BODY WEIGHT; CELL MEMBRANE; DYSTROPHIN; FEMALE; FIBROSIS; GENE KNOCKOUT TECHNIQUES; INFLAMMATION; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; PROTEIN TRANSPORT; SURVIVAL ANALYSIS; UTROPHIN;

EID: 80053899288     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025071     Document Type: Article

References (76)

1. Emery AEH, (1993) Genetics. Duchenne muscular dystrophy, 2nd ed New York Oxford University Press.
2. Mendell JR, Sahenk Z, Prior TW, (1995) The childhood muscular dystrophies: diseases sharing a common pathogenesis of membrane instability. J Child Neurol 10: 150-159.
3. Toussiant M, Chatwin M, Soudon P, (2007) Mechanical ventilation in Duchenne patients with chronic respiratory insufficiency: clinical implications of 20 years published experience. Chron Respir Dis 4: 167-177.
4. Nigro G, Comi LI, Politano L, Bain RJI, (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26: 271-277.
5. Hoffman EP, Brown RH Jr, Kunkel LM, (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919-928.
6. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, et al. (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355: 696-702.
7. Ohlendieck K, Campbell KP, (1991) Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol 115: 1685-1694.
8. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL, (1993) Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A 90: 3710-3714.
9. Villalta SA, Nguyen HX, Deng B, Gotoh T, Tidball JG, (2009) Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet 18: 482-496.
10. Wehling-Henricks M, Jordan MC, Gotoh T, Grody WW, Roos KP, et al. (2010) Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy. PLoS ONE 5 (5): e10763 Available: http://www.plosone.org. Accessed 2011 March 27.
11. Blau HM, Webster C, Pavlath GK, (1983) Defective myoblasts identified in Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 80: 4856-4860.
12. Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS, (1995) Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82: 743-752.
13. Chang WJ, Iannaccone ST, Lau KS, et al. (1996) Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc Natl Acad Sci U S A 93: 9142-9147.
14. Kubes P, Granger DN, (1992) Nitric oxide modulates microvascular permeability. Am J Physiol 262: H611-H615.
15. Clancy RM, Leszczynska-Piziak J, Abramson SB, (1995) Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direction action on the NADPH oxidase. J Clin Invest 90: 1116-1121.
16. Wink DA, Cook JA, Liebmann J, Krishna MC, Mitchell JB, (1995) Nitric oxide (NO) protects against cellular damage by reactive oxygen species. Tox Lett 82/ 83: 221-226.
17. Wehling-Henricks M, Spencer MJ, Tidball JG, (2001) A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol 155: 123-131.
18. Wehling-Henricks M, Jordan MC, Roos KP, Deng B, Tibdall JG, (2005) Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium. Hum Molec Genet 14: 1921-1933.
19. Bulfield G, Siller WG, Wight PA, Moore KJ, (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A 81: 1189-1192.
20. Bia BL, Cassidy PJ, Young ME, Rafael JA, Leighton B, et al. (1999) Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy. J Mol Cell Cardiol 31: 1857-1862.
21. Pastoret C, Sebille A, (1995) mdx mice show progressive weakness and muscle deterioration with age. J Neurol Sci 129: 97-105.
22. Coulton GR, Morgan JE, Partridge TA, Sloper JC, (1988) The mdx mouse skeletal muscle myopathy: I. A histochemical, morphometic and biochemical investigation. Neuropathol and Appl Neurobiol 14: 53-70.
23. Hecker M, Boese M, Schini-Kerth VB, Mulsch A, Busse R, (1995) Characterization of the stable L-arginine-derived relaxing factor released from cytokine-stimulated vascular smooth muscle cells as an NG-hydroxyl-L-arginine nitric oxide adduct. Proc Natl Acad Sci U S A 92: 4671-4675.
24. Buga GM, Singh R, Pervin S, Rogers NE, Schmitz DA, et al. (1996) Arginase activity in endothelial cells: inhibition by NG-hydroxyl-L-arginine during high-output NO production. Am J Physiol 271: H1988-H1998.
25. Hrabak A, Bajor T, Temesi A, Meszaros G, (1996) The inhibitory effect of nitrite, a stable product of nitric oxide (NO) formation, on arginase. FEBS Lett 390: 203-206.
26. Bauer PM, Buga GM, Fukuto JM, Pegg AE, Ignarro LJ, (2001) Nitric oxide inhibits ornithine decarboxylase via S-nitrosylation of cysteine 360 in the active site of the enzyme. J Biol Chem 276: 34458-34464.
27. Shearer JD, Richards JR, Mills CD, Caldwell MD, (1997) Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. Am J Physiol 272: E181-E190.
28. Witte MB, Vogt N, Stuelten C, Gotoh T, Mori M, et al. (2003) Arginase acts as an alternative pathway of L-arginine metabolism in experimental colon anastmosis. J Gastrointest Surg 7: 378-385.
29. Witte MB, Barbul A, (2003) Arginine physiology and its implication for wound healing. Wound Repair Regen 11: 419-423.
30. Curran JN, Winter DC, Bouchier-Hayes D, (2006) Biological fate and clinical implications of arginine metabolism in tissue healing. Wound Repair Regen 14: 376-386.
31. Chamberlain JS, Metzger J, Reyes M, Townsend D, Faulkner JA, (2007) Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J 21: 2195-2204.
32. Blake DJ, Tinsley JM, Davies KE, (1996) Utrophin: a structural and functional comparison to dystrophin. Brain Pathol 6: 37-47.
33. Tinsley JM, Potter AC, Phelps SR, Fisher R, Trickett JI, et al. (1996) Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 384: 349-353.
34. Grady RM, Teng H, Nichol MC, Cunningham JC, Wilkinson RS, et al. (1997) Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 90: 729-738.
35. Deconinck AE, Rafael JA, Skinner JA, Brown SC, Potter AC, et al. (1997) Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90: 717-727.
36. Amalfitano A, Chamberlain JS, (1996) The mdx-amplication-resistant mutation system assay, a simple and rapid polymerase chain reaction-based detection of the mdx allele. Muscle Nerve 19: 1549-1553.
37. Grange RW, Gainer TG, Marschner KM, Talmadge RJ, Stuff JT, (2002) Fast-twitch skeletal muscles of dystrophic mouse pups are resistant to injury from acute mechanical stress. Am J Physiol Cell Physiol 283: C1090-C1101.
38. Minamide LS, Bamburg JR, (1990) A filter paper dye-binding assay for quantitative determination of protein without interference from reducing agents or detergents. Anal Biochem 190: 66-70.
39. Laemmli UK, (1980) Cleavage of structural protein during the assembly of the head of the bacteriophage T4. Nature 227: 680-685.
40. Burnette WN, (1981) 'Western blotting': electrophoretic transfer of proteins from sodium dodecyl sulfate- polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioindinated protein A. Anal Biochem 112: 195-203.
41. Heydemann A, Huber JM, Kakkar R, Wheeler MT, McNally EM, (2004) Functional nitric oxide synthase mislocalization in cardiomyopathy. J Molec Cell Cardiol 36: 213-223.
42. Lee JJ, McGarry MP, Farmer SC, Denzler KL, Larson KA, et al. (1997) Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 185: 2143-2156.
43. Honda H, Kimura H, Rostami A, (1990) Demonstration and phenotypic characterization of resident macrophages in rat skeletal muscle. Immunology 70: 272-277.
44. St. Pierre BA, Tidball JG, (1994) Differential response of macrophage subpopulations to soleus muscle reloading after rat hindlimb suspension. J Appl Physiol 77: 290-297.
45. McLennan IS, (1996) Degenerating and regenerating skeletal muscles contain several subpopulations of macrophages with distinct spatial and temporal distributions. J Anat 188: 17-28.
46. McLennan IS, (1993) Resident macrophages (ED2- and ED3-positive) do not phagocytose degenerating rat skeletal muscle fibres. Cell Tissue Res 272: 193-196.
47. Villalta SA, Rinaldi C, Deng B, Liu G, Fedor B, Tidball JG, (2011) Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype. Hum Mol Genet 20: 790-805.
48. Wehling-Henricks M, Lee JJ, Tidball JG, (2004) Prednisolone decreases cellular adhesion molecules required for inflammatory cell infiltration in dystrophin-deficient skeletal muscle. Neuromuscul Disord 14: 483-490.
49. Kivirikko KI, Laitinen O, Prockop DJ, (1967) Modifications of a specific assay for hydroxyproline in urine. Anal Biochem 19: 249-255.
50. Brenman JE, Chao DS, Gee SH, Craven SE, Santillano DR, et al. (1996) Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α1-syntrophin mediated by PDZ domains. Cell 84: 757-767.
51. Kobayashi YM, Rader EP, Crawford RW, Iyengar NK, Thedens DR, et al. (2008) Sarcolemma-localized nNOS is required to maintain activity after mild exercise. Nature 456: 511-515.
52. Percival JM, Anderson KNE, Gregorevic P, Chamberlain JS, Froehner SC, (2008) Functional deficits in nNOSμ-deficient skeletal muscle: myopathy in nNOS knockout mice. PLoS ONE 3 (10): e3387 Available: http://www.plosone.org. Accessed 2011 March 27.
53. Yue Y, Liu M, Duan D, (2006) C-terminal-truncated microdystrophin recruits dystrobrevin and syntrophin to the dystrophin-associated glycoprotein complex and reduces muscular dystrophy in symptomatic utrophin/dystrophin double-knockout mice. Mol Ther 14: 79-87.
54. Kawano R, Ishizaki M, Maeda Y, Uchida Y, Kimura E, et al. (2008) Transduction of full-length dystrophin to multiple skeletal muscles improves motor performance and life span in utrophin/dystrophin double knockout mice. Mol Ther 16: 825-831.
55. Shiao T, Fond A, Deng B, Wehling-Henricks M, Adams ME, et al. (2004) Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking α- and β1-syntrophins. Hum Mol Genet 13: 1873-1884.
56. Thomas GD, Sander M, Lau KS, Huang PL, Stull JT, et al. (1998) Impaired metabolic modulation of α-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc Natl Acad Sci U S A 95: 15090-15095.
57. Sander M, Chavoshan B, Harris SA, Iannaccone ST, Stull JT, et al. (2000) Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 97: 13818-13823.
58. Wehling-Henricks M, Sokolow S, Lee JJ, Myung KH, Villalta A, et al. (2008) Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy. Hum Molec Genet 17: 2280-2292.
59. Thomazzi SM, Ferreira HH, Conran N, De Nucci G, Antunes E, (2001) Role of nitric oxide on in vitro human eosinophil migration. Biochem Pharmacol 62: 1417-1421.
60. Inkley SR, Oldenburg FC, Vignos PJ, (1974) Pulmonary function in Duchenne muscular dystrophy related to stage of disease. Am J Med 56: 297-306.
61. Moriuchi T, Kagawa N, Mukoyama M, Hizawa K, (1993) Autopsy analysis of the muscular dystrophies. Tokushima J Exp Med 40: 83-93.
62. Finsterer J, Stollberger C, (2003) The heart in human dystrophinopathies. Cardiology 99: 1-19.
63. Miyoshi K, (1991) Echocardiographic evaluation of fibrous replacement in the myocardium of patients with Duchenne muscular dystrophy. Br Heart 66: 452-455.
64. Hainsey TA, Senapati S, Kuhn DE, Rafael JA, (2003) Cardiomyopathic features associated with muscular dystrophy are independent of dystrophin absence in cardiovasculature. Neuromuscul Disord 13: 294-302.
65. Janssen PM, Hiranandani N, Mays TA, Rafael-Fortney JA, (2005) Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice. Am J Physiol Heart Circ Physiol 289: H2373-H2378.
66. Ishizaki M, Suga T, Kimura E, Shiota T, Kawamo R, et al. (2008) Mdx respiratory impairment following fibrosis of the diaphragm. Neuromuscl Disord 18: 342-348.
67. Rafael JA, Tinsley JM, Potter AC, Deconinck AE, Davies KE, (1998) Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice. Nat Genet 19: 79-82.
68. Crisp A, HaiFang Y, Goyenvalle A, Betts C, Moulton HM, et al. (2010) Diaphragm rescue alone prevents heart disfunction in dystrophic mice. Hum Mol Genet 20: 413-421.
69. Thomas GD, Shaul PW, Yuhanna IS, Froehner SC, Adams ME, (2003) Vasomodulation by skeletal muscle-derived nitric oxide requires α-syntrophin-mediated sarcolemmal localization of neuronal nitric oxide synthase. Circ Res 92: 554-560.
70. Wehling-Henricks M, Oltmann M, Rinaldi C, Myung KH, Tidball JG, (2009) Loss of positive allosteric interactions between neuronal nitric oxide synthase and phosphofructokinase contributes to defects in glycolysis and increased fatigability in muscular dystrophy. Hum Mol Genet 18: 3439-3451.
71. Harper SQ, Hauser MA, DelloRusso C, Duan D, Crawford RW, et al. (2002) Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat Med 8: 253-261.
72. Judge LM, Haraguchi M, Chamberlain JS, (2006) Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex. J Cell Sci 119: 1537-1546.
73. Warner LE, DelloRusso C, Crawford RW, Rybakova IN, Patel JR, et al. (2002) Expression of Dp260 in muscle tethers the actin cytoskeleton to the dystrophin-glycoprotein complex and partially prevents dystrophy. Hum Mol Genet 11: 1095-1105.
74. Deng B, Glanzman D, Tidball JG, (2009) Nitric oxide generated by muscle corrects defects in hippocampal neurogenesis and neural differentiation caused by muscular dystrophy. J Physiol 587: 1769-1778.
75. Sakellariou GK, Pye D, Vasilaki A, Zibrik L, Palomero J, et al. (2011) Role of superoxide-nitric oxide interactions in the accelerated age-related loss of muscle mass in mice lacking Cu,Zn superoxide dismutase. Aging Cell Available: http://onlinelibrary.wiley.com/doi/10.1111/j.1474-9726.2011.00709.x/abstract. Accessed 2011 Jul 11.
76. Nguyen HX, Tidball JG, (2003) Expression of a muscle-specific, nitric oxide synthase transgene prevents muscle membrane injury and reduces muscle inflammation during modified muscle use in mice. J Physiol 550: 347-356.